"There are two fairly obvious potential directions that could exploit this kind of research," says Graham Hatfull of the University of Pittsburgh, an author of the study. "The first is the possibility of using the phages directly as a therapy for acne. The second is the opportunity to use phage-derived components for their activities."
P. acnes is a normal resident on human skin, but its numbers increase substantially at puberty, eliciting an inflammatory response that can lead to acne. Although antibiotics can be effective in treating acne, antibiotic-resistant strains of P. acnes have emerged, highlighting the need for better therapies.
Hatfull and his colleagues at the University of Pittsburgh along with scientists from the University of California, Los Angeles, isolated phages and P. acnes bacteria from human volunteers with and without acne, then sequenced the phages' genomes. What they found in those genomes was surprising. The phages were all remarkably similar, sharing more than 85% of their DNA, an unheard of level of similarity among viruses, which usually exhibit a great deal of diversity. This lack of genetic diversity suggests that resistance to phage-based antimicrobial therapy is less likely to develop, they say.
All of the phages carry a gene that makes a protein called endolysin, an enzyme that is thought to break down bacterial cell walls and kill the bacteria. Enzymes like this are used in other applications, says Hatfull, suggesting that endolysin from these phages might also be useful as a topical anti-acne therapeutic. "This work has given us very useful information about the diversity of that set of enzymes and helps pave the way for thinking about potential applications," he says.
From here, Hatfull says, research with these phages will explore how they might be used therapeutically, but phages like these can also provide useful tools, like genes and enzymes, that can be used to manipulate and understand the bacteria they infect. "The information derived from these phages helps contribute toward those kinds of genetic tools," says Hatfull.
mBio® is an open access online journal published by the American Society for Microbiology to make microbiology research broadly accessible. The focus of the journal is on rapid publication of cutting-edge research spanning the entire spectrum of microbiology and related fields. It can be found online at http://mBio.asm.org.
The American Society for Microbiology is the largest single life science society, composed of over 39,000 scientists and health professionals. ASM's mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.
Jim Sliwa | EurekAlert!
Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory
Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
09.12.2016 | Life Sciences
09.12.2016 | Ecology, The Environment and Conservation
09.12.2016 | Health and Medicine